Elevated tryptophan [33,51], IDO activity [30,31,32,33], and kynurenine [33,36,51,52], as well as lower serotonin levels [50] in obesity have been described before; however, the possible impact of this imbalance on metabolic health remains unclear. This evidence concerns the gene IDO1 and obesity disorder.